Pharmaceuticals are developed, designed, and commonly manufactured in laboratory settings. Laboratory testing is an essential need in almost every stage of pharmaceutical production and R&D, from the ...
DGFT's floor prices on select bulk drugs aim to curb Chinese dumping, support PLI-backed manufacturers and lift domestic offtake, though capped medicine prices may limit cost pass-through ...
ANKLESHWAR, India--(BUSINESS WIRE)--RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...
APIs are a key ingredient for making different kinds of medicines in the country. And yet, nearly 65-70% of supplies of APIs in the country are still imported from China. The government has encouraged ...
POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity ...
Good morning, Hubsters. Michael Schoeck here with the US Wire from the New York newsroom. As regular readers of Thursday’s Wire know, I spend a good amount of time talking with confidential sources ...
While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily toward branded drugmakers, generic medicines and the companies that ...
After the U.S. tariff imposition, policymakers must diversify boldly, reform swiftly, and secure India’s pharma supremacy ...
Pharmaceutical Intermediates Market OverviewThe global pharmaceutical intermediates market is witnessing steady expansion as pharmaceutical manufacturing scales worldwide. Valued at approximately USD ...
It’s the most prescribed antibiotic in the United States, used by tens of millions of people every year to treat bacterial infections including pneumonia, stomach ulcers, and strep throat. Yet, it isn ...
Pharmaceutical Technology on MSN
Trump administration ties pricing deals with another nine pharma companies
With the latest batch’s agreements, only three out of the 17 drugmakers initially targeted by Trump have not signed pricing ...
Big Pharma faces uncertainty as the Trump administration pushes MFN drug pricing and 100% tariffs on non-US manufactured patented medicines. Last night's policy announcement around a proposed 100% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback